| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,660 |
3,257 |
$79K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,199 |
2,011 |
$77K |
| 20611 |
|
3,275 |
1,775 |
$55K |
| 64483 |
|
419 |
404 |
$24K |
| 76942 |
|
1,028 |
927 |
$21K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
3,488 |
2,865 |
$16K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
177 |
177 |
$10K |
| J7325 |
Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg |
318 |
179 |
$9K |
| J7324 |
Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose |
81 |
50 |
$5K |
| 64484 |
|
134 |
129 |
$4K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
46 |
46 |
$1K |
| J7320 |
Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg |
99 |
55 |
$1K |
| 20551 |
|
88 |
77 |
$717.49 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
169 |
156 |
$668.25 |
| 20550 |
|
25 |
25 |
$362.70 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
175 |
161 |
$242.07 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
31 |
12 |
$54.61 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
29 |
13 |
$35.65 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
32 |
13 |
$21.44 |